Xebra Shares Commence Trading in the United States
Xebra Brands Ltd. (CSE: XBRA) (OTC: XBRAF) has started trading on the OTC Pink marketplace in the United States. The move aims to expand its market presence in the U.S., where OTC Markets handles over 11,500 securities with a trade volume exceeding US$500 billion year-to-date. Xebra is pursuing an upgrade to the OTCQB market and has applied for registration with the Depository Trust Company to facilitate electronic share settlement. Additionally, the company is entering a consulting agreement for investor relations services worth CA$30,000.
- Xebra now trading on OTC Pink marketplace, increasing accessibility for U.S. investors.
- Application for upgrading to OTCQB and registration with DTC to enhance market presence.
- Engaging a contractor for investor relations may bolster investor engagement.
- Consulting agreement entails a significant share issuance, potentially diluting existing shareholders.
- Forward-looking statements highlight numerous risks including regulatory hurdles and financial uncertainties.
VANCOUVER, BC, Nov. 9, 2021 /PRNewswire/ - Xebra Brands Ltd. ("Xebra") (CSE: XBRA) (OTC: XBRAF) (FSE: 9YC), a cannabis company, is pleased to announce it has commenced trading in the United States on OTC Markets Group's OTC Pink marketplace, under the ticker symbol "XBRAF". OTC Markets is recognized as a leading public financial market for international companies to trade in the U.S. Currently, the OTC Markets has over 11,500 securities trading with more than US
Xebra has applied to upgrade its OTC quotation to the OTCQB market. Companies trading on OTCQB must satisfy minimum reporting standards, pass a bid test, and undergo annual verification. Xebra has also applied to register with the Depository Trust Company (DTC) which, if successful, will allow its shares to be electronically cleared and settled in the United States.
Investor Relations Services
Xebra is entering into a consulting agreement with 2805967 Ontario Ltd. (the "Contractor"), under which the Contractor will provide certain promotional and investor relations services (the "Services").
The Contractor's office is located at 84 Watson's Lane, Dundas, Ontario, L9H 1T3, and can be contacted by telephone at 1-416-819-6286 or by email at stockguerilla@gmail.com.
The Contractor will render the Services from November 2021 to February 2022 (the "Term") in exchange for an aggregate of CA
ON BEHALF OF THE BOARD,
Rodrigo Gallardo
President
Certain information contained in this press release constitutes forward-looking statements under applicable securities laws. Any statements that are not statements of historical fact may be deemed to be forward-looking statements, these include, without limitation, statements regarding Xebra Brands Ltd.'s expectations in respect of its ability to successfully execute its business plan or business model; its ability to provide economic, environmental, social, or any benefits of any type, in the communities it operates in or may operate it in the future; its ability to be a first mover in a country, or to obtain or retain government licenses, permits or authorizations in general, or specifically in Mexico, Colombia, Canada, the Netherlands, or elsewhere; its ability to successfully apply for and obtain trademarks and other intellectual property in any jurisdiction; its ability to be cost competitive; its ability to cultivate, grow, or process hemp or cannabis in Mexico, Colombia, Canada, the Netherlands, or elsewhere and related plans; financial, operational, or any other term relating to the Company's participation in the Dutch trial medicinal cannabis cultivation; its ability to manufacture cannabis beverages, wellness products, or other products; its ability to commercialize or sell cannabis beverages, wellness products, or other products, in Mexico, Colombia, Canada, the Netherlands, or elsewhere; its ability to commercialize or to sell Vicious Citrus Lemonade in 2022 or at any time, in any jurisdiction; its ability to commercialize or to sell Elements wellness products in any jurisdiction at any time; its ability to create wellness products that have a therapeutic effect or benefit; plans for future growth and the direction of the business; financial projections including expected revenues, gross profits, and EBITDA (which is a non-GAAP financial measure); plans to increase product volumes, the capacity of existing facilities, supplies from third party growers and contractors; expected growth of the cannabis industry generally; management's expectations, beliefs and assumptions; events or developments that XEBRA expects to take place in the future; general economic conditions; and other risk factors described in the prospectus of the Company dated September 30, 2021. All statements, other than statements of historical facts, are forward-looking information and statements. The words "aim", "believe", "expect", "anticipate", "contemplate", "target", "intends", "continue", "plans", "budget", "estimate", "may", "will", and similar expressions identify forward-looking information and statements. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by XEBRA as of the dates of such statements, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Known and unknown factors could cause actual results to differ materially from those projected in the forward-looking statements. Such factors include, but are not limited to, the inability of XEBRA to generate sufficient revenues or to raise sufficient funds to carry out its business plan; changes in government legislation, taxation, controls, regulations and political or economic developments in various countries; risks associated with agriculture and cultivation activities generally, including inclement weather, access to supply of seeds, poor crop yields, and spoilage; compliance with import and export laws of various countries; significant fluctuations in cannabis prices and transportation costs; the risk of obtaining necessary licenses and permits; inability to identify, negotiate and complete a potential acquisition for any reason; the ability to retain key employees; dependence on third parties for services and supplies; non-performance by contractual counter-parties; general economic conditions; and the continued growth in global demand for cannabis products and the continued increase in jurisdictions legalizing cannabis; and the timely receipt of regulatory approval for license applications. The foregoing list is not exhaustive and XEBRA undertakes no obligation to update or revise any of the foregoing except as required by law. Many of these uncertainties and contingencies could affect XEBRA's actual performance and cause its actual performance to differ materially from what has been expressed or implied in any forward-looking statements made by, or on behalf of, XEBRA. Readers are cautioned that forward-looking statements are not guarantees of future performance and readers should not place undue reliance on such forward-looking statements. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those set out in such statements.
View original content to download multimedia:https://www.prnewswire.com/news-releases/xebra-shares-commence-trading-in-the-united-states-301419247.html
SOURCE Xebra Brands Ltd.
FAQ
What is the significance of Xebra trading under XBRAF on the OTC Pink marketplace?
When did Xebra start trading in the United States?
What are the plans for Xebra regarding upgrading its OTC quotation?
What is the amount involved in Xebra's consulting agreement for investor relations?
